147 related articles for article (PubMed ID: 10584127)
1. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity.
Bläse M; Zaruba MM; Santo-Hoeltje L; Bamberg M; Hoffmann W; Rodemann HP
Strahlenther Onkol; 1999 Nov; 175(11):563-8. PubMed ID: 10584127
[TBL] [Abstract][Full Text] [Related]
2. Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha.
Hoffmann W; Bläse MA; Santo-Hoeltje L; Herskind C; Bamberg M; Rodemann HP
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):991-8. PubMed ID: 10571207
[TBL] [Abstract][Full Text] [Related]
3. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
[TBL] [Abstract][Full Text] [Related]
4. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
Ryu S; Kim OB; Kim SH; He SQ; Kim JH
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
[TBL] [Abstract][Full Text] [Related]
5. 13-cis retinoic acid and interferon-alpha +/- irradiation in the treatment of squamous-cell carcinomas.
Hoffmann W; Schiebe M; Hirnle P; Souchon R; Clemens M; Adamietz I; Bamberg M
Int J Cancer; 1997 Feb; 70(4):475-7. PubMed ID: 9033659
[No Abstract] [Full Text] [Related]
6. 13-cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro.
DeLaney TF; Afridi N; Taghian AG; Sanders DA; Fuleihan NS; Faller DV; Nogueira CP
Cancer Res; 1996 May; 56(10):2277-80. PubMed ID: 8625298
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G
Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916
[No Abstract] [Full Text] [Related]
8. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of fractionated-dose irradiation by retinoic acid plus interferon.
Gerweck LE; Zaidi ST; Delaney TF
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):611-5. PubMed ID: 9806522
[TBL] [Abstract][Full Text] [Related]
10. Increased radiosensitivity by a combination of 9-cis-retinoic acid and interferon-y in breast cancer cells.
Windbichler GH; Hensler E; Widschwendter M; Posch A; Daxenbichler G; Fritsch E; Marth C
Gynecol Oncol; 1996 Jun; 61(3):387-94. PubMed ID: 8641621
[TBL] [Abstract][Full Text] [Related]
11. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
[TBL] [Abstract][Full Text] [Related]
12. Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro.
Malone C; Schiltz PM; Nayak SK; Shea MW; Dillman RO
Clin Cancer Res; 1999 Feb; 5(2):417-23. PubMed ID: 10037192
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma.
Gravis G; Pech-Gourgh F; Viens P; Alzieu C; Camerlo J; Oziel-Taieb S; Jausseran M; Maraninchi D
Anticancer Drugs; 1999 Apr; 10(4):369-74. PubMed ID: 10378671
[TBL] [Abstract][Full Text] [Related]
14. Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma.
Kawata M; Ogi K; Nishiyama K; Miyamoto S; Nakagaki T; Shimanishi M; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2017 Nov; 46(10):979-985. PubMed ID: 28640935
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
[TBL] [Abstract][Full Text] [Related]
16. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
[TBL] [Abstract][Full Text] [Related]
18. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
19. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study.
Nikolaou AC; Fountzilas G; Daniilidis I
J Laryngol Otol; 1996 Sep; 110(9):857-61. PubMed ID: 8949297
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
